Oracle says AI will save it from the SaaSpocalypse, not bring it on42m ago Congress Is Suddenly Waking Up to the AI Doomsday Threat1h ago Don’t ask ChatGPT 'What should I do?' — this simple prompt helps you make better decisions yourself1h ago Extreme Networks’ Agent ONE Coworker moves AI networking from dashboards to answers1h ago Introducing ChatGPT for Financial Services2h ago Tesla unveils driverless Cybercab in Japan for 1st time2h ago The AI safety vibe shift2h ago Sam Altman met with top power utilities about securing the electrical grid. He offered one possible solution: OpenAI's cyber services.2h ago OpenAI Is Open to Slowing Cutting-Edge AI, CEO Sam Altman Tells Staff3h ago Tencent-Backed Chipmaker Enflame Jumps 188% in Shanghai Debut3h ago Salesforce introduces Enterprise AI Harness, AI Control Plane3h ago The Race for the Next Big Weight-Loss Drug Is On—and China Wants In3h ago How Social Media Platforms Are Identifying AI Content4h ago DeepSeek launches V4.1-Flash and retires V4-Pro, its flagship model4h ago

Oracle says AI will save it from the SaaSpocalypse, not bring it on42m ago Congress Is Suddenly Waking Up to the AI Doomsday Threat1h ago Don’t ask ChatGPT 'What should I do?' — this simple prompt helps you make better decisions yourself1h ago Extreme Networks’ Agent ONE Coworker moves AI networking from dashboards to answers1h ago Introducing ChatGPT for Financial Services2h ago Tesla unveils driverless Cybercab in Japan for 1st time2h ago The AI safety vibe shift2h ago Sam Altman met with top power utilities about securing the electrical grid. He offered one possible solution: OpenAI's cyber services.2h ago OpenAI Is Open to Slowing Cutting-Edge AI, CEO Sam Altman Tells Staff3h ago Tencent-Backed Chipmaker Enflame Jumps 188% in Shanghai Debut3h ago Salesforce introduces Enterprise AI Harness, AI Control Plane3h ago The Race for the Next Big Weight-Loss Drug Is On—and China Wants In3h ago How Social Media Platforms Are Identifying AI Content4h ago DeepSeek launches V4.1-Flash and retires V4-Pro, its flagship model4h ago

Checked for new stories 25m ago

Updates on Nature Biotechnology

Every AI story we track on Nature Biotechnology — 1 story so far, each summarized in our own words and linked back to the publisher that reported it.

Pulled from 123 sources

This week

Healthcare4 min read

Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial

Covered by 2 sources4d ago

That's everything we have on Nature Biotechnology right now